Long-term Results of Interwoven Nitinol Stents to Treat the Radiocephalic Anastomotic Arteriovenous Fistula Stenosis

Abstract

Introduction:

Juxta-anastomotic stenosis (JXAS) is a common problem afflicting the arteriovenous fistula (AVF). This study aimed to evaluate the safety and long-term efficacy of an interwoven nitinol stent (Supera, Abbott Vascular, Santa Clara, CA, USA) in the treatment of radiocephalic AVF JXAS.

Methods:

A single-center, retrospective, observational study was conducted of patients with failing AVF due to JXAS treated with an interwoven nitinol stent. End points included JXAS target lesion primary patency, access circuit primary patency, assisted access circuit primary patency, and endovascular intervention rate (EIR).

Results:

Sixty patients were treated with a Supera stent in the JXAS between February 2014 and March 2020. One patient was excluded (AVF used for illicit drug use), leaving 59 patients (67.8% male, mean age 66.9 ± 11.4 years [range: 40–84]) with typical medical comorbidities. Overall, 45.8% of patients had previous AVF intervention. The stent was inserted with a 100% technical success rate with a mean follow-up of 729.6 ± 456.0 days (range: 5–2182 days). Juxta-anastomotic stenosis target lesion primary patency was 68.2 ± 6.6%, 53.3 ± 7.5%, and 46.2 ± 8.1% at 12, 24, and 36 months, respectively. The EIR was .64 (0–3.29) procedures/patient/year, after which the assisted access circuit primary patency rate was 94.3 ± 3.2% at 12, 24, and 36 month time points. Three thrombosed circuits occurred which were all successfully salvaged with no difference in patency by indication for procedure and no AVFs lost/abandoned out to 3 years. Avoidance of stent post-dilatation and the presence of stent mal-apposition were associated with improved primary patency, and reduced EIR, which may suggest an importance in vessel preparation prior to stent implantation.

Conclusion:

Interwoven nitinol stent treatment of the failing AVF with JXAS results in promising 3 year JXAS patency, with a low rate of endovascular re-intervention for those circuits developing restenosis. All AVFs were maintained over 3 years, demonstrating this treatment allows for long-term radiocephalic AVF vascular access.

Keywords

vascular access arteriovenous fistula dialysis anastomosis stent *endovascular treatment/therapy

Get full access to this article

View all access options for this article.

References

National Kidney Foundation. KDOQI Clinical Practice Guideline for Vascular Access: 2018. New York, NY: National Kidney Foundation; 2018.

Dhingra

Young

Hulbert-Shearon

, et al. Type of vascular access and mortality in U.S. Kidney Int. 2001;60(4):1443–1451.

Ravani

Palmer

Oliver

, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–473.

Perera

Mueller

Kubaska

, et al. Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg. 2004;18(1):66–73.

Nassar

Ayus

JC.

Infectious complications of the hemodialysis access. Kidney Int. 2001;60(1):1–13.

Lee

Manns

Taub

, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–622.

Duncan

Ferguson

Faris

Incidence of the radial steal syndrome in patients with Brescia fistula for hemodialysis: its clinical significance. J Vasc Surg. 1986;4(2):144–147.

Malik

Tuka

Kasalova

, et al. Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access. 2008;9(3):155–166.

Quencer

Arici

Arteriovenous fistulas and their characteristic sites of stenosis. AJR Am J Roentgenol. 2015;205(4):726–734.

10.

Beathard

Arnold

Jackson

, et al; Physician Operators Forum of RMS Lifeline. Aggressive treatment of early fistula failure. Kidney Int. 2003;64(4):1487–1494.

11.

Falk

Teodorescu

Lou

, et al. Treatment of “swing point stenoses” in hemodialysis arteriovenous fistulae. Clin Nephrol. 2003;60(1):35–41.

12.

Vassalotti

JA.

Arteriovenous fistula stenosis: new terminology. Semin Dial. 2004;17(3):243.

13.

Sivanesan

How

Bakran

Sites of stenosis in AV fistulae for haemodialysis access. Nephrol Dial Transplant. 1999;14(1):118–120.

14.

Badero

Salifu

Wasse

, et al. Frequency of swing-segment stenosis in referred dialysis patients with angiographically documented lesions. Am J Kidney Dis. 2008;51(1):93–98.

15.

Ene-Iordache

Cattaneo

Dubini

, et al. Effect of anastomosis angle on the localization of disturbed flow in “side-to-end” fistulae for haemodialysis access. Nephrol Dial Transplant. 2013;28(4):997–1005.

16.

Konner

Nonnast-Daniel

Ritz

The arteriovenous fistula. J Am Soc Nephrol. 2003;14(6):1669–1680.

17.

Bharat

Jaenicke

Shenoy

A novel technique of vascular anastomosis to prevent juxta-anastomotic stenosis following arteriovenous fistula creation. J Vasc Surg. 2012;55(1):274–280.

18.

Thomas

Peden

Crowe

, et al. Interwoven nitinol stents to treat radiocephalic anastomotic arteriovenous fistula stenosis. J Endovasc Ther. 2019;26(3):394–401.

19.

Maleckis

Deegan

Poulson

, et al. Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations. J Mech Behav Biomed Mater. 2017;75:160–168.

20.

Carroll

Colley

Thomas

, et al. Tracking geometric and hemodynamic alterations of an arteriovenous fistula through patient-specific modelling. Comput Methods Programs Biomed. 2020;186:105203.

21.

Gunasekera

Thomas

, et al. Tomographic PIV analysis of physiological flow conditions in a patient-specific arteriovenous fistula. Exp Fluids. 2020;61:253.

22.

Thomas

Katib

, et al. A comprehensive renal vascular access clinic results in improved patient outcomes and reduced costs. ANZ J Surg. 2018;88(3):185–190.

23.

Fahrtash

Kairaitis

Gruenewald

, et al. Defining a significant stenosis in an autologous radio-cephalic arteriovenous fistula for hemodialysis. Semin Dial. 2011;24(2):231–238.

24.

Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(suppl 1):S248–S273.

25.

Aslam

Thomas

Vijayan

, et al. Nitinol stent-assisted maturation of the dysfunctional cannulation zone in the immature arteriovenous fistula. J Vasc Access. 2020;21:908–916.

26.

Australia and New Zealand Dialysis and Transplant Registry. 41st report, chapter 3: mortality in end stage kidney disease. Australia and New Zealand Dialysis and Transplant Registry; 2018. https://www.anzdata.org.au/wp-content/uploads/2019/09/c03_mortality_2018_ar_2019_v1.0_20191202.pdf. Accessed December 1, 2022.

27.

Mortamais

Papillard

Girouin

, et al. Endovascular treatment of juxta-anastomotic venous stenoses of forearm radiocephalic fistulas: long-term results and prognostic factors. J Vasc Interv Radiol. 2013;24(4):558–564; quiz 565.

28.

Swinnen

Lean Tan

Allen

, et al. Juxta-anastomotic stenting with aggressive angioplasty will salvage the native radiocephalic fistula for dialysis. J Vasc Surg. 2015;61(2):436–442.

29.

Pan

Liang

Lin

, et al. Metallic stent placement for treating peripheral outflow lesions in native arteriovenous fistula hemodialysis patients after insufficient balloon dilatation. AJR Am J Roentgenol. 2005;184(2):403–409.

30.

Quaretti

Leati

Moramarco

, et al. Percutaneous transanastomotic stent graft deployment to salvage dysfunctional native forearm radiocephalic fistulae: feasibility and primary patency at 12 months. J Vasc Interv Radiol. 2018;29(7):986–992.

31.

Carroll

Varcoe

Barber

, et al. Reduction in anastomotic flow disturbance within a modified end-to-side arteriovenous fistula configuration: results of a computational flow dynamic model. Nephrology (Carlton). 2019;24:245–251.

32.

Lee

Kim

, et al. Assessing radiocephalic wrist arteriovenous fistulas of obtuse anastomosis using computational fluid dynamics and clinical application. J Vasc Access. 2016;17(6):512–520.

33.

Kharboutly

Deplano

Bertrand

, et al. Numerical and experimental study of blood flow through a patient-specific arteriovenous fistula used for hemodialysis. Med Eng Phys. 2010;32(2):111–118.

34.

Karydis

Bevis

Beckitt

, et al. An implanted blood vessel support device for arteriovenous fistulas: a randomized controlled trial. Am J Kidney Dis. 2020;75(1):45–53.

35.

Werner

Paetzold

Banning-Eichenseer

, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–868.